Obesity drugs won’t be covered by Medicare under 2026 CMS policy
This decision is a blow for Eli Lilly and Novo Nordisk, who had both previously endorsed the proposed expansion.
Streeting promises UK pharma quick action on VPAG frustration
ABL Bio and GSK link on neurodegenerative conditions
KalVista licenses commercialisation rights for HAE to Kaken in Japan
UK Government to invest $764m into new health data service
EU president to meet pharma leaders as tariff threat looms
Analysis
View More
Themes
View MoreGoogle-backed Isomorphic Labs raises $600m to advance AI drug discovery
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
1 of 2
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
EU Health Data Space strikes a chord in EU harmonisation plans
Mastering compliance and copyright in healthcare and MedComms
AstraZeneca director says AI must be a “thought partner” in drug discovery
MeiraGTx and Hologen launch AI-backed gene therapy venture